Severe atypical iliac wing fracture associated with long-term bisphosphonate use

被引:0
作者
Kelliher, John [1 ,2 ]
Rahmani, George [1 ]
Carey, John J. [1 ,2 ]
Bergin, Diane [1 ,2 ]
机构
[1] Univ Hosp Galway, Galway, Ireland
[2] Univ Galway, Galway, Ireland
关键词
Bisphosphonates; Pelvic fractures; Atypical fractures; Postmenopausal; FEMUR FRACTURE; BONE TURNOVER; FEMORAL-SHAFT; ALENDRONATE; THERAPY; WOMEN; RISK;
D O I
10.1007/s00256-024-04738-9
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundBisphosphonate use is associated with atypical non-traumatic fractures, which are most commonly seen in the femur.Case presentationWe report a 63-year-old postmenopausal woman who presented acutely with progressively worsening lumbar pain radiating to her left hip for 10 days. There was no antecedent trauma. On examination, the patient could not bear weight on her left leg due to the severity of the pain. Radiography and computed tomography of the pelvis demonstrated an iliac wing fracture which was treated conservatively. The patient had a significant past medical history of breast cancer and intense bisphosphonate use for several years which was discontinued 3 years previously. No discrete bone lesion was seen at the fracture site on computed tomography, and there was no evidence of metastatic disease elsewhere. A dual-energy X-ray absorptiometry scan showed the lowest bone mineral density T-score of - 1.2. A diagnosis of an atypical fracture related to long-term bisphosphonate therapy was made.ConclusionTo the best of our knowledge, this is the first reported case of an isolated iliac wing fracture associated with long-term bisphosphonate therapy in the literature. Whilst the incidence of such fractures is exceedingly rare, it is an important differential in patients with atypical fractures on long-term bisphosphonates.
引用
收藏
页码:627 / 631
页数:5
相关论文
共 18 条
  • [1] Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series
    Armamento-Villareal, Reina
    Napoli, Nicola
    Diemer, Kathryn
    Watkins, Marcus
    Civitelli, Roberto
    Teitelbaum, Steven
    Novack, Deborah
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2009, 85 (01) : 37 - 44
  • [2] Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
    Black, Dennis M.
    Geiger, Erik J.
    Eastell, Richard
    Vittinghoff, Eric
    Li, Bonnie H.
    Ryan, Denison S.
    Dell, Richard M.
    Adams, Annette L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (08) : 743 - 753
  • [3] Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management
    Black, Dennis M.
    Abrahamsen, Bo
    Bouxsein, Mary L.
    Einhorn, Thomas
    Napoli, Nicola
    [J]. ENDOCRINE REVIEWS, 2019, 40 (02) : 333 - 368
  • [4] Alendronate and estrogen effects in postmenopausal women with low bone mineral density
    Bone, HG
    Greenspan, SL
    McKeever, C
    Bell, N
    Davidson, M
    Downs, RW
    Emkey, R
    Meunier, PJ
    Miller, SS
    Mulloy, AL
    Recker, RR
    Weiss, SR
    Heyden, N
    Musliner, T
    Suryawanshi, S
    Yates, AJ
    Lombardi, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) : 720 - 726
  • [5] Detection of Atypical Femur Fractures
    Cheung, Angela M.
    McKenna, Malachi J.
    de Laarschot, Denise M. van
    Zillikens, M. Carola
    Peck, Valerie
    Srighanthan, Jeevitha
    Lewiecki, E. Michael
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2019, 22 (04) : 506 - 516
  • [6] Breast-Cancer Adjuvant Therapy with Zoledronic Acid
    Coleman, Robert E.
    Marshall, Helen
    Cameron, David
    Dodwell, David
    Burkinshaw, Roger
    Keane, Maccon
    Gil, Miguel
    Houston, Stephen J.
    Grieve, Robert J.
    Barrett-Lee, Peter J.
    Ritchie, Diana
    Pugh, Julia
    Gaunt, Claire
    Rea, Una
    Peterson, Jennifer
    Davies, Claire
    Hiley, Victoria
    Gregory, Walter
    Bell, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15) : 1396 - 1405
  • [7] Deas Crystal M, 2017, Consult Pharm, V32, P144, DOI 10.4140/TCP.n.2017.144
  • [8] Fleisch H, 2000, BISPHOSPHONATES BONE
  • [9] Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis
    Gedmintas, Lydia
    Solomon, Daniel H.
    Kim, Seoyoung C.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (08) : 1729 - 1737
  • [10] Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
    Hadji, Peyman
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 69 (01) : 73 - 82